Joseph Green

Title: Joseph Green: Innovator in Pharmaceutical Compositions

Introduction

Joseph Green is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions aimed at improving health outcomes. With a total of 2 patents to his name, Green's work reflects a commitment to advancing medical science.

Latest Patents

Among his latest patents, Green has developed fibrinolytic compositions that provide a water-soluble complex of a proteolytic enzyme linked covalently to a polymeric substance. This innovation is crucial for creating effective pharmaceutical treatments. Additionally, he has worked on biologically active substances, discovering that certain non-ionic surfactants can effectively reduce serum cholesterol levels in both animals and humans. These surfactants are incorporated into pharmaceutical compositions at a minimum of 20 percent, ensuring that the (C.sub.2 H.sub.4 O) groups constitute 0 to 30 percent of the total molecular weight, while the (C.sub.3 H.sub.6 O) groups have a partial molecular weight ranging from 2250 to 3250. The preparation of these surfactants involves the sequential addition of ethylene diamine, with 'Tetronic 701' and 'Tetronic 702' being suitable candidates.

Career Highlights

Joseph Green is currently associated with Beecham Group Plc, where he continues to innovate and contribute to the pharmaceutical industry. His work has garnered attention for its potential impact on health and wellness.

Collaborations

Green has collaborated with notable colleagues, including Michael Anthony Cawthorne and Brian Morgan, who share his passion for advancing pharmaceutical science.

Conclusion

Joseph Green's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work not only showcases his expertise but also reflects the potential for improving health outcomes through scientific advancements.